AfriNEXT project aims to develop and promote a vibrant, strong and sustainable research culture Africa. The project will create a critical mass of African world-class researchers capable of carrying out high quality research on local health priorities with a strong emphasis on maternal and child health. It is a great pleasure to collaborate with research and academic hubs of Burkina Faso, Ghana, Guinea, Cameroon, the Democratic Republic of Congo and Ethiopia, lead by Prof. Seni Kouanda.
The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone,
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including
Emerging and re-emerging viral infections represent one of the most complex challenges for global public health. Among these, Enterovirus D68 (EV-D68) is emerging with increasing urgency due to recurring outbreaks